Is intravenous thrombolysis useful in carotid artery dissection with tandem occlusion?

Montserrat González Delgado1, Raquel García, Eduardo Murias

  • 1Neurology Service, Central University Hospital of Asturias, Oviedo, Spain. mglezdelgado@yahoo.es

Insights

Intravenous thrombolysis is safe for cervical artery dissection patients. Even with tandem lesions, like internal carotid artery occlusion and middle cerebral artery embolus, this treatment can lead to successful recanalization and good outcomes.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Interventional Neurology

Background:

  • Cervical artery dissection (CAD) is a significant cause of stroke in young adults.
  • Intravenous thrombolysis (IVT) has traditionally been a contraindication in CAD due to concerns about worsening dissection or hemorrhage.
  • Recent evidence suggests IVT may be safe and effective in select CAD cases.

Observation:

  • A case of a patient presenting with occlusive internal carotid artery (ICA) dissection and a concurrent middle cerebral artery (MCA) embolus is described.
  • The patient exhibited collateral circulation via the ophthalmic artery and anterior communicating artery.
  • The patient successfully underwent IV thrombolysis.

Findings:

  • Successful recanalization of the MCA was achieved following IV thrombolysis.
  • The patient experienced a good clinical outcome.
  • Tandem lesions in CAD, specifically ICA occlusion with MCA occlusion, do not preclude successful IVT.

Implications:

  • IV thrombolysis is a viable treatment option for acute ischemic stroke secondary to cervical artery dissection, even in the presence of tandem occlusions.
  • The presence of robust collateral circulation may predict successful recanalization in MCA emboli associated with CAD.
  • Further research is warranted to establish definitive guidelines for IVT in complex CAD presentations.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...